Latest Articles
-
What Led To A 24% Fall In Alaska Air Stock Since 2020?
After an 18% fall month-to-date, at the current levels, Alaska Air stock (NYSE: ALK) looks undervalued, in our view. ALK stock fell from $48 in early March to $39 now. The MTD -18% return for ALK marks an underperformance with the broader S&...
-
Is Bristol Myers Squibb Stock A Better Pick Over Its Industry Peer?
We believe that Bristol Myers Squibb stock (NYSE: BMY) is currently a better pick than its industry peer, Eli Lilly stock (NYSE: LLY), given its better growth prospects. Eli Lilly is trading at 10.7x trailing revenues compared to 3.2x for BM...
-
What To Expect From Nike’s Stock Post Q3 Results?
[Note: Nike FY 2022 ended May 31, 2022] Nike’s stock (NYSE: NKE), a company designing, developing, and marketing footwear, apparel, equipment, and accessory products, is scheduled to report its fiscal 2023 third-quarter results on Tues...
-
Yelp Stock Down 14% Over Six Months. What’s Next?
After a 14% decline over the last six months, at the current price of around $31 per share, we believe Yelp’s stock (NASDAQ: YELP), an online site for discovering local businesses ranging from bars, restaurants, and cafes, to hairdressers...
-
Does Diageo Stock Have More Room For Growth?
Diageo’s stock (NYSE: DEO) has seen a fall of 4% this year, compared with 2% returns for the broader S&P500 index. After its recent underperformance vis-a-vis the broader markets, we believe DEO stock has ample room for growth, and investo...
-
Should You Buy The Botox Maker Over Johnson & Johnson Stock?
We believe that AbbVie stock (NYSE: ABBV) is currently a better pick than its industry peer, Johnson & Johnson stock (NYSE: JNJ), given its better growth prospects. Although AbbVie is trading at 4.8x trailing revenues compared to 4.2x fo...
-
EV Component Stocks Are Outperforming This Year. Should You Buy?
Our theme of EV Supplier stocks has fared relatively well this year, rising by about 8% year-to-date, compared to the S&P 500 which has declined by about 2% over the same time frame. This comes after a relatively difficult 2022, which saw th...
-
Is JPMorgan Stock Fairly Priced?
JPMorgan’s stock (NYSE: JPM) has lost 5% YTD, as compared to the 2% rise in the S&P500 over the same period. Further, the stock is currently trading at $126 per share, which is 20% below its fair value of $157 – Trefis’ estimate for JPMo...
-
Why AMD Stock Appears Overvalued
Advanced Micro Devices stock (NASDAQ: AMD) has gained about 50% year-to-date, considerably outperforming the broader S&P 500. So what’s driving the recent surge in the stock? Firstly, technology stocks in general have fared well, with...
-
What’s Happening With Juniper Stock?
Juniper (NYSE:JNPR), a company that sells networking products, including routers, switches, network management software, network security products, and software-defined networking technology, has seen its stock underperform a bit, falling by abou...
-
What To Expect From Credit Suisse Stock?
Credit Suisse’s stock (NYSE: CS) has lost approximately 29% YTD, as compared to the 3% rise in the S&P500 over the same period. Further, CS stock is currently trading around $2 per share, which is 14% below its fair value of just below $3 ...
-
SLB Stock Looks Attractive At $46
After an 11% decline over the last week, at the current price of around $46 per share, we believe SLB’s stock (NYSE: SLB), formerly known as Schlumberger, which provides oil field services including drilling, completion, and production so...
-
What Is Driving Growth For Abbott Stock?
After a 10% fall year-to-date, at the current levels, Abbott stock (NYSE: ABT) has room for growth, in our view. ABT stock fell from $110 in early January to $99 now. The YTD -10% return for ABT marks an underperformance with the broader S&...
-
What’s Happening With Motorola Solutions Stock?
Motorola Solutions Inc. (NYSE: MSI) – one of the largest suppliers of land-mobile-radio (LMR) solutions – has seen its stock outperform. The stock remains up by about 4% year-to-date, while it has gained about 16% over the last 12 m...
-
Is Pfizer Stock Undervalued At $40?
Pfizer stock (NYSE: PFE) has seen a fall of 21% this year, compared with 2% returns for the broader S&P500 index. Pfizer stock has been weighed down due to an anticipated decline of over 30% in its 2023 sales, primarily due to lower sales o...
